Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Prospector who wrote (2670)	7/7/1998 12:15:00 AM
From: Profiteer	Respond to of 5402

EIGHT PAGES! OJ's lawyers had fewer notes... Ha ha <eom>

To: Prospector who wrote (2670)	7/7/1998 4:26:00 AM
From: SecurPro	Read Replies (8) \| Respond to of 5402

I am new to this post, but not to this industry. I have traded drug and biotech stocks for over 10 years and have myself been involved in the industry as well as many of my close friends. We have recently discussed Sanguine and in particular we looked at the product, market, and investment opportunity. I knew the most about the company so I gave them a briefing. Basically, our conclusion was that this is a real long shot to achieve what they are after. So holding a large amount of shares for a long period would not be wise for someone to do. I AM SURE THIS IS WHAT YOU WANTED TO HEAR Don't get excited. I am writing this to help the less educated investor in this situation. In order to reap financial rewards from this stock you must time the news pieces. The different phases of the trial will be key. If you study companies that had similar products, you will find that the process for approval is lllloooooonnnnngggggg. Therefore, save yourself some headaches and wait for the dips before approximate scheduled news and you can do fine with this one.